Literature DB >> 7133631

Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings.

H Yoshioka, Y Katsume, H Akune.   

Abstract

In an adult Japanese monkey (Macaca fuscatus), intravenous injections of adrenalin were repeated daily: 0.125 mg/kg for 7 days and 0.375 mg/kg from the 11th day on. In a cynomolgus monkey (Macaca irus), daily injections were carried out with intravenous adrenalin (0.11 mg/kg for 12 days and a double dose from the 13th day on) and also with intramuscular prednisolone. After the 39th injection in the former and after the 32nd injection in the latter monkey, disciform serous retinal detachment was seen to occur in the posterior pole region, and fluorescein angiography revealed multiple dye leakage spots at the level of the retinal pigment epithelium. Sometimes these changes subsided, but on continuing injections, these changes recurred on new locations. Two types of fluorescein leakage spots were recognized, i.e. ink blot type with progressive simple enlargement with time and the mushroom or jet type showing these patterns during enlargement. No abnormality was found in the optic disc, retinal vessels or in the choroidal circulation. The fluorescein angiographic findings were in close resemblance with those seen in the human central serous chorioretinopathy. It was discussed that these fundus changes of the monkey eye produced by repeated adrenalin injections would serve as a good animal model of the human disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7133631     DOI: 10.1159/000309239

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  30 in total

1.  Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy.

Authors:  J A Montero; J M Ruiz-Moreno
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

Review 2.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 3.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

4.  Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy.

Authors:  Mehmet Yasin Teke; Ufuk Elgin; Pinar Nalcacioglu-Yuksekkaya; Emine Sen; Pinar Ozdal; Faruk Ozturk
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

5.  [Bilateral retinal detachment].

Authors:  C Melzer; F G Holz; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

6.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

7.  Smokestack leak in central serous chorioretinopathy.

Authors:  Dhiren Bujarborua; Pran N Nagpal; Manab Deka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-15       Impact factor: 3.117

8.  Central serous chorioretinopathy complicating systemic corticosteroid treatment.

Authors:  M Wakakura; S Ishikawa
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

9.  Central serous chorioretinopathy and risk for obstructive sleep apnea.

Authors:  Thellea K Leveque; Le Yu; David C Musch; Ronald D Chervin; David N Zacks
Journal:  Sleep Breath       Date:  2007-12       Impact factor: 2.816

10.  Central serous chorioretinopathy after dacryocystorhinostomy operation on the same side.

Authors:  Lakshmikanta Mondal; Sayan Basu; Krishnapada Baidya; Gautam Bhaduri
Journal:  Indian J Ophthalmol       Date:  2009 Jan-Feb       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.